Mutual of America Capital Management’s Revolution Medicines RVMD Stock Holding History

Mutual of America Capital Management’s Portfolio RVMD Stock Details RVMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$365K	Buy	+1,947	New	+$284K	﹤0.01%	1231

Other funds holding RVMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

National Bank of Canada Montreal, Quebec, Canada $140B AUM 46.34% 1-Year Est. Return

Mutual of America Capital Management's RVMD Position: Q2 2026 in Review

Mutual of America Capital Management opened a new position in Revolution Medicines (RVMD) in Q2 2026: 1,947 shares worth $365K. The stake represents ﹤0.01% of the portfolio and ranks #1231 among its holdings.

420 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

Mutual of America Capital Management held 1,947 shares of Revolution Medicines worth $365K as of Q2 2026.
Revolution Medicines was a new Mutual of America Capital Management position in Q2 2026.
Revolution Medicines made up ﹤0.01% of Mutual of America Capital Management's portfolio in Q2 2026, its #1231 holding.
420 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Mutual of America Capital Management's 13F filing for Q2 2026, filed 11 Aug 2026.